Literature DB >> 18719947

Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 months.

Elise L Lev1, Lucille Sanzero Eller, Glen Gejerman, John Kolassa, Joan Colella, Janine Pezzino, Patricia Lane, Ravi Munver, Michael Esposito, John Sheuch, Vincent Lanteri, Ihor Sawczuk.   

Abstract

GOALS OF WORK: Treatments for early-stage prostate cancer (PCa) are highly effective; therefore, research studies that explore quality of life (QOL) issues associated with different treatments are important. The purposes of this study were to (a) examine differences among treatment groups of men treated with either radiation therapies or radical prostatectomy for PCa and (b) examine quality of life outcomes over time. PATIENTS AND METHODS: We report outcomes 6 and 12 months after 159 men began treatment for PCa with either one of two types of radiation treatment (intensity-modulated radiation therapy plus high dose rate or intensity-modulated radiation therapy plus seed implantation) or radical prostatectomy. MAIN
RESULTS: Significant differences among groups are described. Significant predictors of QOL at 6 months included urinary, bowel, and sexual symptoms, anxiety, depression, problem-focused coping, and physiological self-efficacy. Significant predictors of QOL at 12 months were urinary and bowel symptoms, stress, depression, problem-focused coping, and physiological self-efficacy. Demographic variables, race, and living status were significant predictors of quality of life at 12 months.
CONCLUSIONS: Physiological symptoms and psychological symptoms were both significant predictors of QOL. The psychological factors that predicted quality of life in this study have potential for intervention and point to the next stage of the research.

Entities:  

Mesh:

Year:  2008        PMID: 18719947     DOI: 10.1007/s00520-008-0493-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  17 in total

1.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

2.  Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument.

Authors:  David I Ben-Tovim; Melissa L G Dougherty; Alan M F Stapleton; Carole B Pinnock
Journal:  Urology       Date:  2002-03       Impact factor: 2.649

3.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

4.  Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of life.

Authors:  Lisa C Campbell; Francis J Keefe; Daphne C McKee; Christopher L Edwards; Steven H Herman; Lawrence E Johnson; O Michael Colvin; Colleen M McBride; Craig F Donattuci
Journal:  J Pain Symptom Manage       Date:  2004-11       Impact factor: 3.612

5.  A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding.

Authors:  Frank J Penedo; Ivan Molton; Jason R Dahn; Biing-Jiun Shen; Dave Kinsinger; Lara Traeger; Scott Siegel; Neil Schneiderman; Michael Antoni
Journal:  Ann Behav Med       Date:  2006-06

6.  An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer.

Authors:  Christopher F Sharpley; David R H Christie
Journal:  Psychooncology       Date:  2007-07       Impact factor: 3.894

7.  Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

Authors:  Adam J Ball; Bethany Gambill; Michael D Fabrizio; John W Davis; Robert W Given; Donald F Lynch; Mark Shaves; Paul F Schellhammer
Journal:  J Endourol       Date:  2006-10       Impact factor: 2.942

8.  Social barriers to emotional expression and their relations to distress in male and female cancer patients.

Authors:  Sandra G Zakowski; Casey Harris; Nancy Krueger; Kimberly K Laubmeier; Susan Garrett; Robert Flanigan; Peter Johnson
Journal:  Br J Health Psychol       Date:  2003-09

9.  Measuring quality of life in palliative care.

Authors:  D F Cella
Journal:  Semin Oncol       Date:  1995-04       Impact factor: 4.929

10.  Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account?

Authors:  Ronald C Chen; Jack A Clark; Judith Manola; James A Talcott
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

View more
  15 in total

1.  Higher-intensity exercise helps cancer survivors remain motivated.

Authors:  Eric Martin; Claudio Battaglini; Beth Hands; Fiona L Naumann
Journal:  J Cancer Surviv       Date:  2015-11-19       Impact factor: 4.442

2.  Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy.

Authors:  Christine Miaskowski; Steven M Paul; Bruce A Cooper; Kathryn Lee; Marylin Dodd; Claudia West; Bradley E Aouizerat; Laura Dunn; Patrick S Swift; William Wara
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

3.  Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.

Authors:  George Rodrigues; Xiaomei Yao; D Andrew Loblaw; Michael Brundage; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

4.  [Transrectal prostate biopsy: effective anesthesia, complications, and influence on clinical outcome after radical prostatectomy].

Authors:  G Müller; H Borrusch; I Knop; U Otto
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

Review 5.  Intervention for patient reported urinary symptoms in prostate cancer survivors: Systematic review.

Authors:  Kisook Kim; Ji-Su Kim
Journal:  J Cancer Surviv       Date:  2017-08-22       Impact factor: 4.442

Review 6.  Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Authors:  George Rodrigues; Xiaomei Yao; D Andrew Loblaw; Michael Brundage; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2013-11       Impact factor: 1.862

7.  Early assessment of patient satisfaction and health-related quality of life following robot-assisted radical prostatectomy.

Authors:  Eun Yong Choi; Jeongyun Jeong; Dong Il Kang; Kelly Johnson; Thomas Jang; Isaac Yi Kim
Journal:  J Robot Surg       Date:  2010-08-29

8.  A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.

Authors:  Farhana Haseen; Liam J Murray; Roisin F O'Neill; Joe M O'Sullivan; Marie M Cantwell
Journal:  Trials       Date:  2010-08-12       Impact factor: 2.279

9.  Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer.

Authors:  Ruth Curtis; AnnMarie Groarke; Frank Sullivan
Journal:  Sci Rep       Date:  2014-07-04       Impact factor: 4.379

10.  Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study.

Authors:  Frank Peinemann; Alexander Michael Labeit; Christian Thielscher; Michael Pinkawa
Journal:  BMJ Open       Date:  2014-06-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.